Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence

Pulmonary disease (PD) caused by nontuberculous mycobacteria is an emerging infection mainly in countries where the incidence of tuberculosis is in decline. It affects an elderly population, often with underlying chronic lung diseases, but its epidemiology shows significant regional variation. Guide...

Full description

Saved in:

Bibliographic Details
Published in:	Expert review of anti-infective therapy Vol. 11; no. 10; pp. 1065 - 1077
Main Authors:	van Ingen, Jakko, Ferro, Beatriz E, Hoefsloot, Wouter, Boeree, Martin J, van Soolingen, Dick
Format:	Journal Article
Language:	English
Published:	England Informa Healthcare 01.10.2013 Taylor & Francis Expert Reviews Ltd
Subjects:	Aged Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - therapeutic use atypical mycobacteria Clinical Trials as Topic Drug Administration Schedule Drug Dosage Calculations Drug therapy Evidence-Based Medicine Human immunodeficiency virus Humans lung disease Lung diseases Medical case management Mycobacterial infections Mycobacterium abscessus Mycobacterium avium Mycobacterium avium complex Mycobacterium chelonae Mycobacterium fortuitum Mycobacterium Infections, Nontuberculous - drug therapy Mycobacterium Infections, Nontuberculous - microbiology Mycobacterium kansasii Mycobacterium malmoense Mycobacterium xenopi nontuberculous mycobacteria Nontuberculous Mycobacteria - classification Nontuberculous Mycobacteria - drug effects Nontuberculous Mycobacteria - physiology Survival Analysis Treatment Outcome
ISSN:	1478-7210, 1744-8336, 1744-8336
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!